Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (461-470 of 683) with videos related to

Pageof 69
Sort By:
Neoplasia (New York, N.Y.)|July 24, 2010
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancersDimitra Dafou, Barbara Grun, John Sinclair, et al.
The Oncologist|February 3, 2026
Clinical outcomes of Lutetium-177-PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancerMargo Brooke Gerke, Akshay Bedmutha, Angelo Marra, et al.
Frontiers in Oncology|June 21, 2013
Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasionJohn I Risinger, Jay Allard, Uma Chandran, et al.
Gynecologic Oncology|August 31, 2016
Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and RecommendationsIlana Cass, Linda R Duska, Stephanie V Blank, et al.
JCO Precision Oncology|September 14, 2022
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate CancerJacob E Berchuck, Daniel Boiarsky, Rebecca Silver, et al.
Nature Communications|May 11, 2026
Ascites protects against ferroptosis and enables the peritoneal growth of ovarian cancerYasaman Setayeshpour, Ssu-Yu Chen, Divya L Dayanidhi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate CancerKonrad H Stopsack, Joseph Vijai, Michael Conry, et al.
Heart (British Cardiac Society)|February 17, 2021
Comparative effectiveness of oral anticoagulants in everyday practiceA John Camm, Keith A A Fox, Saverio Virdone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 19, 2012
Common variation in Nemo-like kinase is associated with risk of ovarian cancerKristen N Stevens, Linda E Kelemen, Xianshu Wang, et al.
Gynecologic Oncology|September 23, 2017
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyKathleen N Moore, David Tritchler, Kenneth M Kaufman, et al.
Pageof 69

Showing results (461-470 of 683) with videos related to

Sort By:
Pageof 69
Neoplasia (New York, N.Y.)|July 24, 2010
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancersDimitra Dafou, Barbara Grun, John Sinclair, et al.
The Oncologist|February 3, 2026
Clinical outcomes of Lutetium-177-PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancerMargo Brooke Gerke, Akshay Bedmutha, Angelo Marra, et al.
Frontiers in Oncology|June 21, 2013
Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasionJohn I Risinger, Jay Allard, Uma Chandran, et al.
Gynecologic Oncology|August 31, 2016
Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and RecommendationsIlana Cass, Linda R Duska, Stephanie V Blank, et al.
JCO Precision Oncology|September 14, 2022
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate CancerJacob E Berchuck, Daniel Boiarsky, Rebecca Silver, et al.
Nature Communications|May 11, 2026
Ascites protects against ferroptosis and enables the peritoneal growth of ovarian cancerYasaman Setayeshpour, Ssu-Yu Chen, Divya L Dayanidhi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate CancerKonrad H Stopsack, Joseph Vijai, Michael Conry, et al.
Heart (British Cardiac Society)|February 17, 2021
Comparative effectiveness of oral anticoagulants in everyday practiceA John Camm, Keith A A Fox, Saverio Virdone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 19, 2012
Common variation in Nemo-like kinase is associated with risk of ovarian cancerKristen N Stevens, Linda E Kelemen, Xianshu Wang, et al.
Gynecologic Oncology|September 23, 2017
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyKathleen N Moore, David Tritchler, Kenneth M Kaufman, et al.
Pageof 69